Evidence map›Paper›PMID 39451765›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care.

Jessica L Nickerson, Chloe Cyr, Riley J Arseneau, Stacey N Lee, Stefanie Condon-Oldreive, George Zogopoulos, Keith Roberts, Christina A Kim, Sylvia S W Ng, Masoom Haider and 11 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jessica L NickersonAllumiqs Corporation, Halifax, NS B3H 0A8, Canada.
Chloe CyrCraig's Cause Pancreatic Cancer Society, Halifax, NS B3K 5M3, Canada.ORCID 0000-0002-0321-1861
Riley J ArseneauCraig's Cause Pancreatic Cancer Society, Halifax, NS B3K 5M3, Canada.ORCID 0000-0003-1379-1211
Stacey N LeeCraig's Cause Pancreatic Cancer Society, Halifax, NS B3K 5M3, Canada.ORCID 0000-0001-6518-8006
Stefanie Condon-OldreiveCraig's Cause Pancreatic Cancer Society, Halifax, NS B3K 5M3, Canada.
George ZogopoulosMcGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Keith RobertsInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
Christina A KimPaul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.ORCID 0000-0003-3847-2583
Sylvia S W NgSection of Medical Oncology and Hematology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.
Masoom HaiderJoint Department of Medical Imaging, Sinai Health System, Toronto, ON M5G 1X6, Canada.ORCID 0000-0002-7165-8315
Eva VillalbaQuebec Cancer Coalition, Saint-Lambert, QC J4P 2J7, Canada.ORCID 0000-0001-5576-0339
Leah StephensonAll.Can, Pentincton, BC V2A 0B2, Canada.
Erica TsangDepartment of Medicine, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.
Brent JohnstonDepartment of Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada.ORCID 0000-0001-5456-2824
Boris Gala-LopezDepartment of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada.ORCID 0000-0003-1179-2085
Valerie CooperSouth East Local Health Integration Network, Belleville, ON K8N 5K3, Canada.
Breffni HannonDepartment of Supportive Care, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.
Anne GangloffFaculty of Medicine, Laval University, Quebec, QC G1V 0A6, Canada.ORCID 0000-0002-6848-6559
Sharlene GillBC Cancer, Vancouver, BC V5Z 4E6, Canada.ORCID 0000-0003-3306-3617
Filomena Servidio-ItalianoColorectal Cancer Resource and Action Network (CCRAN), Toronto, ON M4W 3E2, Canada.ORCID 0009-0009-1079-2295
Ravi RamjeesinghDivision of Medical Oncology, Dalhousie University, Halifax, NS B3H 2Y9, Canada.ORCID 0000-0001-5584-3505

Funding

AstraZeneca (Canada) Education GrantCraig's Cause Pancreatic Cancer Society Education GrantViatris Education Grant
6 · The paper itself

Abstract

Pancreatic cancer is a complex malignancy associated with poor prognosis and high symptom burden. Optimal patient care relies on the integration of various sectors in the healthcare field as well as innovation through research. The Canadian National Pancreas Conference (NPC) was co-organized and hosted by Craig's Cause Pancreatic Cancer Society and The Royal College of Physicians and Surgeons in November 2023 in Montreal, Canada. The conference sought to bridge the gap between Canadian healthcare providers and researchers who share the common goal of improving the prognosis, quality of life, and survival for patients with pancreatic cancer. The accredited event featured discussion topics including diagnosis and screening, value-based and palliative care, pancreatic enzyme replacement therapy, cancer-reducing treatment, and an overview of the current management landscape. The present article reviews the NPC sessions and discusses the presented content with respect to the current literature.

Indexed as

Pancreatic NeoplasmsCanadaHumanscollaborative caremultidisciplinary meetingpancreatic cancer

Identifiers

PMID39451765
PMCPMC11506161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.